Hit your running and weight loss goals while on GLP-1s with the help of mindful strategies.

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced continued nationwide momentum as ...

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new ...

Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m2 or greater - ...

Weight loss journeys are as unique as the individuals who embark on them. We all have different body types, lifestyles, health histories and goals that shape what we need to achieve lasting results.

The FDA has approved a pill form of the popular injectable obesity drug Wegovy. People on the highest dose dropped about 14 percent of their starting weight after 64 weeks, with a high number of ...

Data: N.C. Department of Health and Human Services; Chart: Axios Visuals North Carolina is one of 13 states whose Medicaid programs cover GLP-1s for weight loss treatment, and their usage in the state ...

Midland Health’s Weigh to Success returns in 2026 with lifestyle medicine, CBT, medications and bariatric surgery to help ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...